Published in Int J Immunopathol Pharmacol on October 14, 2010
Coherent somatic mutation in autoimmune disease. PLoS One (2014) 0.78
A plasma proteomic approach in Rett syndrome: classical versus preserved speech variant. Mediators Inflamm (2013) 0.75
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer Chemother Pharmacol (2010) 2.32
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer. Breast Cancer Res Treat (2011) 1.87
A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study. Eur J Cancer (2008) 1.47
Improving adherence to and persistence with oral therapy of osteoporosis. Osteoporos Int (2015) 1.46
Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am J Epidemiol (2005) 1.44
Malignant lymphoma presenting as Tietze's syndrome. Arthritis Rheum (2002) 1.39
Sjögren's syndrome and pure red cell aplasia. Clin Exp Rheumatol (1996) 1.37
Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the knee. Osteoarthritis Cartilage (2003) 1.29
Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study. Ann Oncol (2005) 1.28
Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. Ann Oncol (2001) 1.16
Mechanisms of impaired bone strength in type 1 and 2 diabetes. Nutr Metab Cardiovasc Dis (2010) 1.16
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vasc Health Risk Manag (2010) 1.15
Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib. Br J Cancer (2008) 1.10
The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Calcif Tissue Int (2008) 1.08
Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer. Br J Cancer (2011) 1.07
Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study. Calcif Tissue Int (2003) 1.07
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group. J Clin Oncol (2003) 1.03
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II study. Ann Oncol (2001) 1.02
Simvastatin reduces MMP-3 level in interleukin 1beta stimulated human chondrocyte culture. Ann Rheum Dis (2004) 1.02
Asymptomatic carriage of verocytotoxin-producing Escherichia coli O157 in farm workers in Northern Italy. Epidemiol Infect (2004) 1.02
A family outbreak of Escherichia coli O157 haemorrhagic colitis caused by pork meat salami. Epidemiol Infect (2007) 1.01
Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy. Ann Oncol (2006) 1.00
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study. Br J Cancer (2008) 0.99
Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane. Bone (2006) 0.99
Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone (2001) 0.99
Sonographic study of calcaneal entheses in erosive osteoarthritis, nodal osteoarthritis, rheumatoid arthritis and psoriatic arthritis. Scand J Rheumatol (2003) 0.98
Electrophysiologic evaluation of local steroid injection in carpal tunnel syndrome. Arch Phys Med Rehabil (1991) 0.98
[Guidelines on prevention and treatment of vitamin D deficiency. Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS)]. Reumatismo (2011) 0.97
Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer. J Med Virol (1998) 0.96
Bone ultrasonography at phalanxes in patients with Rett syndrome: a 3-year longitudinal study. Bone (2007) 0.96
Osteoporosis risk in patients with chronic obstructive pulmonary disease: the EOLO study. J Clin Densitom (2009) 0.96
Cerebrotendinous xanthomatosis: pathophysiological study on bone metabolism. J Neurol Sci (1993) 0.96
Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells. Br J Cancer (2005) 0.96
Osteoporosis treatment and fracture incidence: the ICARO longitudinal study. Osteoporos Int (2008) 0.93
Granulocyte activation after coronary angioplasty in humans. Circulation (1990) 0.93
Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study. Osteoporos Int (2006) 0.93
High bone turnover is associated with accelerated bone loss but not with increased fracture risk in men aged 50 and over: the prospective MINOS study. Ann Rheum Dis (2007) 0.92
Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer. Br J Cancer (2011) 0.92
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients. Br J Cancer (2008) 0.92
A new contrast agent for radiological and dissection studies of the arterial network of anatomic specimens. Surg Radiol Anat (2013) 0.92
Induced psoriasis after rituximab therapy for rheumatoid arthritis: a case report and review of the literature. Rheumatol Int (2012) 0.92
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study. Breast Cancer Res Treat (2008) 0.91
[Articular involvement in the course of primary hypogammaglobulinemia]. Recenti Prog Med (2001) 0.90
Antianemic and potential anti-inflammatory activity of desferrioxamine: possible usefulness in rheumatoid arthritis. Clin Exp Rheumatol (1986) 0.90
Long-term i.v. Ig treatment in systemic lupus erythematosus. Clin Exp Rheumatol (1994) 0.90
The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer. Eur J Intern Med (2008) 0.90
Ultrastructural anatomy of contracted capsules around textured implants in augmented breasts. Ann Plast Surg (2001) 0.90
Mild brachydactyly type A1 maps to chromosome 2q35-q36 and is caused by a novel IHH mutation in a three generation family. J Med Genet (2003) 0.89
Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with Systemic Sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study. Int J Immunopathol Pharmacol (2011) 0.89
Fluid flow through nanometer-scale channels. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 0.88
Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group. Ann Oncol (2002) 0.87
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data. Anticancer Res (2006) 0.87
Quantitative ultrasound calcaneous measurements: normative data for the Italian population. the ESOPO study. J Clin Densitom (2007) 0.87
Reference typing report for complement receptor 1 (CR1). Exp Clin Immunogenet (1998) 0.87
Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone. Bone (2006) 0.87
Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis. Osteoporos Int (2013) 0.87
[Guidelines for the diagnosis, prevention and treatment of osteoporosis]. Reumatismo (2010) 0.85
Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients. Lung Cancer (2006) 0.85
VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide. Br J Cancer (2013) 0.84
Clinical impact of BNP and other emerging biomarkers in heart failure evaluation and management. Minerva Cardioangiol (2012) 0.84
Sulfasalazine-induced immune thrombocytopenia. Postgrad Med J (2007) 0.84
Polymyositis associated with simvastatin. Lancet (1997) 0.84
Long-term treatment with calcitriol in postmenopausal osteoporosis. Metabolism (1990) 0.84
Methods and clinical applications of total body absorptiometry. J Nucl Med Allied Sci (1987) 0.83
Aminoacylase I deficiency due to ACY1 mRNA exon skipping. Clin Genet (2013) 0.83
Clinical associations in patients with hand osteoarthritis. Scand J Rheumatol (2012) 0.83
Main endocrine modulators of vitamin D hydroxylases in human pathophysiology. J Steroid Biochem (1987) 0.82
Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome. Int J Clin Pract (2007) 0.82
In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists. Eur J Clin Invest (2007) 0.82
Cadmium influences the 5-Fluorouracil cytotoxic effects on breast cancer cells. Eur J Histochem (2012) 0.82
Magnetic resonance imaging in Tietze's syndrome. Clin Exp Rheumatol (2008) 0.82
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group. J Clin Oncol (2001) 0.82
The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis. J Endocrinol Invest (1984) 0.82
Feasibility of quantitative ultrasound measurements on the humerus of newborn infants for the assessment of the skeletal status. Osteoporos Int (2004) 0.81
Effects of chondroitin sulfate and interleukin-1beta on human chondrocyte cultures exposed to pressurization: a biochemical and morphological study. Osteoarthritis Cartilage (2000) 0.81
Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies. J Nucl Med (1988) 0.81
KISS1 and KISS1R expression in the human and rat carotid body and superior cervical ganglion. Eur J Histochem (2011) 0.81
Choline kinase active site provides features for designing versatile inhibitors. Curr Top Med Chem (2014) 0.81
Effects of clodronate on synovial fluid levels of some inflammatory mediators, after intra-articular administration to patients with synovitis secondary to knee osteoarthritis. Boll Soc Ital Biol Sper (2001) 0.81
Infection by CagA-positive Helicobacter pylori strains in patients with ischemic heart disease: prevalence and association with exercise-induced electrocardiographic abnormalities. Dig Dis Sci (2002) 0.81
Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study. Calcif Tissue Int (2010) 0.81
Secondary osteoporosis. Aging (Milano) (1998) 0.81
Dating of palaeoanthropological nuragic skeletal tissues using electron paramagnetic resonance (EPR) spectrometry. Ital J Anat Embryol (1999) 0.81
Effect of a long-term treatment with 1,25-dihydroxyvitamin D3 on osteocalcin in postmenopausal osteoporosis. Calcif Tissue Int (1986) 0.80
Effects of parathyroid hormone and calcitonin on plasma and nephrogenous cyclic adenosine-3',5'-monophosphate in normal subjects and in pathological conditions. Eur J Clin Invest (1980) 0.80
Synovial fluid levels of bradykinin correlate with biochemical markers for cartilage degradation and inflammation in knee osteoarthritis. Osteoarthritis Cartilage (2013) 0.80
Comparison between the analgesic and therapeutic effects of a musically modulated electromagnetic field (TAMMEF) and those of a 100 Hz electromagnetic field: blind experiment on patients suffering from cervical spondylosis or shoulder periarthritis. J Med Eng Technol (2002) 0.80